Click here to view the full article from the UConn Today.
The Seahorse Bioscience XFp Instrument (Agilent Technologies) is used for the analysis of cellular metabolism and energy utilization (i.e., the “energy phenotype”) of cell samples. This technology allows researchers to connect physiological traits of cells with genomic and proteomic data to give significant insights into pathological states (cancer, diabetes, cardiovascular and neurodegenerative disease).
Exciting opportunities offered through the MCB Professional Science Master’s (PSM) program May term and summer session 2016. Hands on training on state-of-the-art instruments through short, intense modular training courses. This May term and summer session we will be offering six modules. Open to graduate and undergraduate students with the required prerequisites.
In recognition of her outstanding contributions, professional dedication to inspiring student learning and commitment to education, we congratulate Jacqui!
The UConn SPARK Technology Commercialization Fund provides that invaluable initial support to move technologies along the innovation continuum so they can more quickly and successfully reach the market, benefit society, and impact economic growth in Connecticut. View full article here.
PITCH (Program in Innovative Therapeutics for Connecticut’s Health), is supported by a three-year, $10 million investment by BioInnovation Connecticut, and helps innovators speed bioscience discoveries toward commercialization.